Real-World Evidence (RWE) is increasingly becoming crucial in life sciences, pharmaceuticals, and healthcare. A consultant specializing in RWE, for example, one working at IQVIA, should be proficient in managing and executing a variety of projects. Here are the top 10 projects they should be able to do:
1. RWE Database Design & Management: They should be capable of designing and managing complex databases, sourcing from electronic health records (EHR), insurance claim databases, patient registries, and other real-world data (RWD) sources.
2. Comparative Effectiveness Research (CER): They should be proficient in conducting CER using RWE to establish the relative efficiency and safety of various therapeutic approaches.
3. Patient Journey Mapping: Using RWE, they should be able to accurately map a patient’s journey through the healthcare system. This includes identifying key touchpoints, treatment patterns, and factors affecting treatment outcomes.
4. Regulatory Submission Support: The consultant should be able to utilize RWE to provide support for regulatory submissions. This includes supporting label extensions, post-marketing surveillance, and risk management strategies.
5. Post-Marketing Surveillance: They should be able to set up systems for monitoring drug performance post-launch, capturing adverse event rates, and helping to provide additional data on safety and efficacy.
6. Health Economics and Outcomes Research (HEOR): Using RWE, they should be able to conduct HEOR studies that prove the economic value and real-world effectiveness of medical interventions.
7. Predictive Modeling: They should be proficient in designing and developing predictive models to forecast disease progression, patient outcomes, and healthcare costs using RWE.
8. Evidence Generation for Payers: The consultant should be able to leverage RWE to generate strong evidence for payers. This can help justify the cost of a therapy or a product and its placement within treatment algorithms.
9. Clinical Trial Design and Implementation Support: They should be able to use RWE to enhance clinical trial design and execution. For instance, RWE can be used to select suitable patient populations or identify appropriate endpoints for a trial.
10. Developing Disease Management Programs: They should be capable of using RWE to aid in the development of comprehensive disease management programs, providing insight into population health management strategies, optimizing healthcare resources, and improving patient care.
It’s worth noting that these projects often require advanced knowledge and expertise in biostatistics, epidemiology, and healthcare informatics, along with proficiency in specific software and database management tools. They also need to be aware of regulatory guidelines and ethical considerations related to the use of RWE.
In the European context, RWE can be and has been applied in various projects:
1. RWE Database Design & Management: The European Health Data & Evidence Network (EHDEN) is an initiative that aims to harmonize more than 100 million health records across Europe. A consultant may be involved in managing such a database or extracting insights from it.
2. Comparative Effectiveness Research (CER): A study conducted in the UK used RWE to compare the effectiveness of novel oral anticoagulants and warfarin in patients with atrial fibrillation.
3. Patient Journey Mapping: Consultants at IQVIA would have used RWE in projects like the UK’s National Health Service (NHS) Digital’s data on patient journeys through different care settings to understand the progression of diseases such as diabetes or COPD.
4. Regulatory Submission Support: In 2017, the European Medicines Agency (EMA) accepted RWE from Novartis in the form of data from registries to expand the label for carolimus, an immunosuppressant drug.
5. Post-Marketing Surveillance: A consultant might be engaged in projects similar to the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) initiative, which facilitates the conduct of post-authorization safety studies (PASS) and other pharmacoepidemiological studies.
6. Health Economics and Outcomes Research (HEOR): A consultant could conduct studies like the one completed in Germany that used RWE to show that a new type of insulin had better outcomes and was cost-effective compared to other treatments.
7. Predictive Modeling: The European Translational Information & Knowledge Management Services (eTRIKS), a platform that supports the sharing and re-use of pre-competitive translational research data, offers numerous opportunities for predictive modeling projects using RWE.
8. Evidence Generation for Payers: The collaboration between Roche and NHS England to use RWE for monitoring the performance of the breast cancer drug Kadcyla in the real world is an example of generating evidence for payers.
9. Clinical Trial Design and Implementation Support: The GetReal Initiative in the EU, which aimed to facilitate the incorporation of RWE into drug development, could involve a consultant in supporting trial design and implementation.
10. Developing Disease Management Programs: An RWE consultant might be involved in projects similar to the Swedish National Diabetes Register, which uses RWE to enhance care and develop disease management programs.
These examples are illustrative of the types of projects an RWE consultant could handle. Each project would be customized to the particular needs and objectives of the client, whether they’re a pharmaceutical company, healthcare provider, or governmental organization.